This project explores EEG biomarkers for personalized neuromodulation. It uses resting-state EEG signatures to predict treatment efficacy and support individualized tACS decisions for patients with refractory auditory hallucinations.


This project explores EEG biomarkers for personalized neuromodulation. It uses resting-state EEG signatures to predict treatment efficacy and support individualized tACS decisions for patients with refractory auditory hallucinations.